发明名称 |
COMBINATIONS OF A LIPOSOMAL WATER-SOLUBLE CAMPTOTHECIN WITH CETUXIMAB OR BEVACIZUMAB |
摘要 |
Compositions which comprise a liposomal water-soluble camptothecin and optionally a liposomal fluoropyrimidine in combination with a vascular epithelial growth factor (VEGF) inhibitor such as cetuximab or an epidermal growth factor receptor (EGFR) inhibitor such as bevacizumab are useful in achieving enhanced therapeutic effects for the treatment of cancer. |
申请公布号 |
EP2344161(A4) |
申请公布日期 |
2014.07.09 |
申请号 |
EP20090820164 |
申请日期 |
2009.10.16 |
申请人 |
CELATOR PHARMACEUTICALS CORPORATION |
发明人 |
TARDI, PAUL;MAYER, LAWRENCE;BERMUDES, DAVID |
分类号 |
A61K31/4745;A61K9/127;A61K31/496;A61K31/513;A61K31/7072;A61K39/395;A61P35/00 |
主分类号 |
A61K31/4745 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|